These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33768492)

  • 1. ETV6-related thrombocytopenia associated with a transient decrease in von Willebrand factor.
    Kanamaru Y; Uchiyama T; Kaname T; Yanagi K; Ohara O; Kunishima S; Ishiguro A
    Int J Hematol; 2021 Aug; 114(2):297-300. PubMed ID: 33768492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia.
    Topka S; Vijai J; Walsh MF; Jacobs L; Maria A; Villano D; Gaddam P; Wu G; McGee RB; Quinn E; Inaba H; Hartford C; Pui CH; Pappo A; Edmonson M; Zhang MY; Stepensky P; Steinherz P; Schrader K; Lincoln A; Bussel J; Lipkin SM; Goldgur Y; Harit M; Stadler ZK; Mullighan C; Weintraub M; Shimamura A; Zhang J; Downing JR; Nichols KE; Offit K
    PLoS Genet; 2015 Jun; 11(6):e1005262. PubMed ID: 26102509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel phenotypes observed in patients with
    Karastaneva A; Nebral K; Schlagenhauf A; Baschin M; Palankar R; Juch H; Heitzer E; Speicher MR; Höfler G; Grigorow I; Urban C; Benesch M; Greinacher A; Haas OA; Seidel MG
    J Med Genet; 2020 Jun; 57(6):427-433. PubMed ID: 31704777
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia.
    Melazzini F; Palombo F; Balduini A; De Rocco D; Marconi C; Noris P; Gnan C; Pippucci T; Bozzi V; Faleschini M; Barozzi S; Doubek M; Di Buduo CA; Kozubik KS; Radova L; Loffredo G; Pospisilova S; Alfano C; Seri M; Balduini CL; Pecci A; Savoia A
    Haematologica; 2016 Nov; 101(11):1333-1342. PubMed ID: 27365488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia.
    Noetzli L; Lo RW; Lee-Sherick AB; Callaghan M; Noris P; Savoia A; Rajpurkar M; Jones K; Gowan K; Balduini C; Pecci A; Gnan C; De Rocco D; Doubek M; Li L; Lu L; Leung R; Landolt-Marticorena C; Hunger S; Heller P; Gutierrez-Hartmann A; Xiayuan L; Pluthero FG; Rowley JW; Weyrich AS; Kahr WHA; Porter CC; Di Paola J
    Nat Genet; 2015 May; 47(5):535-538. PubMed ID: 25807284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETV6-related thrombocytopenia and leukemia predisposition.
    Di Paola J; Porter CC
    Blood; 2019 Aug; 134(8):663-667. PubMed ID: 31248877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors.
    Poggi M; Canault M; Favier M; Turro E; Saultier P; Ghalloussi D; Baccini V; Vidal L; Mezzapesa A; Chelghoum N; Mohand-Oumoussa B; Falaise C; Favier R; Ouwehand WH; Fiore M; Peiretti F; Morange PE; Saut N; Bernot D; Greinacher A; BioResource N; Nurden AT; Nurden P; Freson K; Trégouët DA; Raslova H; Alessi MC
    Haematologica; 2017 Feb; 102(2):282-294. PubMed ID: 27663637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of a germline ETV6 variant associated with inherited thrombocytopenia, acute lymphoblastic leukemia, and salivary gland carcinoma in childhood.
    Yoshino H; Nishiyama Y; Kamma H; Chiba T; Fujiwara M; Karaho T; Kogashiwa Y; Morio T; Yan K; Bessho F; Takagi M
    Int J Hematol; 2020 Aug; 112(2):217-222. PubMed ID: 32367453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease.
    Jilma-Stohlawetz P; Knöbl P; Gilbert JC; Jilma B
    Thromb Haemost; 2012 Aug; 108(2):284-90. PubMed ID: 22740102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline ETV6 mutations and predisposition to hematological malignancies.
    Feurstein S; Godley LA
    Int J Hematol; 2017 Aug; 106(2):189-195. PubMed ID: 28555414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.
    Zhang MY; Churpek JE; Keel SB; Walsh T; Lee MK; Loeb KR; Gulsuner S; Pritchard CC; Sanchez-Bonilla M; Delrow JJ; Basom RS; Forouhar M; Gyurkocza B; Schwartz BS; Neistadt B; Marquez R; Mariani CJ; Coats SA; Hofmann I; Lindsley RC; Williams DA; Abkowitz JL; Horwitz MS; King MC; Godley LA; Shimamura A
    Nat Genet; 2015 Feb; 47(2):180-5. PubMed ID: 25581430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis.
    Casonato A; Sartorello F; Pontara E; Gallinaro L; Bertomoro A; Grazia Cattini M; Daidone V; Szukowska M; Pagnan A
    Thromb Haemost; 2007 Dec; 98(6):1182-7. PubMed ID: 18064311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis of neonatal alloimmune thrombocytopenia: Type 2B von Willebrand disease.
    Penel-Page M; Meunier S; Fretigny M; Le Quellec S; Boisseau P; Vinciguerra C; Ternisien C; Rugeri L
    Platelets; 2017 Dec; 28(8):825-828. PubMed ID: 28436749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline deletion of
    Rampersaud E; Ziegler DS; Iacobucci I; Payne-Turner D; Churchman ML; Schrader KA; Joseph V; Offit K; Tucker K; Sutton R; Warby M; Chenevix-Trench G; Huntsman DG; Tsoli M; Mead RS; Qu C; Leventaki V; Wu G; Mullighan CG
    Blood Adv; 2019 Apr; 3(7):1039-1046. PubMed ID: 30940639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A family having type 2B von Willebrand disease with an R1306W mutation: Severe thrombocytopenia leads to the normalization of high molecular weight multimers.
    Ozeki M; Kunishima S; Kasahara K; Funato M; Teramoto T; Kaneko H; Fukao T; Kondo N
    Thromb Res; 2010 Feb; 125(2):e17-22. PubMed ID: 19740526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETV6 in hematopoiesis and leukemia predisposition.
    Hock H; Shimamura A
    Semin Hematol; 2017 Apr; 54(2):98-104. PubMed ID: 28637624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.